Top 3 Takeover Targets for Pfizer
The year is already off to a good start with mergers and acquisitions in the biopharma industry. Source: BioSpace
Paragon Bioservices to Create 200 New Jobs in Expansion
The company expects the new facility will include commercial manufacturing capabilities in 18 to 24 months. Source: BioSpace
3 Biotechs That Have Doubled Investors' Money in Less Than a Year
Having a stock double in value is a good thing. Source: BioSpace
Bay Area's GigaGen Moves to New Space to Accommodate Growth
GigaGen completed relocation to One Tower Place in late December 2017. Source: BioSpace
New Kid Tmunity Banks $100M From Gilead and Facebook Billionaire Sean Parker
The funds raised will partly go towards funding two clinical trials that have already opened. Source: BioSpace
Denali Top Exec Jumps Ship for Bay Area Anti-Aging Startup Alkahest
Hannestad will be responsible for Alkahest's clinical programs in Alzheimer's and Parkinson's Disease. Source: BioSpace
Amgen Jumps as Migraine Drug Wows in Late-Stage Study
Amgen’s migraine drug Aimovig continues to impress with its efficacy in late-stage studies. Source: BioSpace
Gilead's Kite Pays $135M for Ex-Agensys R&D Building
The latest acquisition makes it the highest amount paid for a flex R&D building in Los Angeles County. Source: BioSpace
Lawmakers End Federal Shutdown — for Three Weeks, At Least
Congress voted Monday afternoon to re-open the government after failing to pass a stopgap measure over the weekend, which shut down federal agencies — but concerns remain about an upcoming…
Milan Laboratories Cited Over Quality Control, Sanitary Concerns
The FDA issued drugmaker Milan Laboratories (India) a Form 483 over quality and sanitation problems observed during an August inspection of the firm’s Navi Mumbai facility. Source: Drug Industry Daily
- Go to the previous page
- 1
- …
- 190
- 191
- 192
- 193
- 194
- 195
- 196
- …
- 610
- Go to the next page